Lisdexamfetamine Dimesylate Tablet, Chewable — FDA Drug Shortage

Current — Takeda Pharmaceuticals USA Inc.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Tablet, Chewable (tablet, chewable) from Takeda Pharmaceuticals USA Inc. with status Current. The shortage was first posted on Jul 14, 2023.

Shortage details

Status
Current
Company
Takeda Pharmaceuticals USA Inc.
Package NDC
59417-116-01
Dosage Form
Tablet, Chewable
Presentation
Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01)
Initial Posting
Jul 14, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.